Skip to content

Warby Parker WRBY Investment Purchases

Investment Purchases at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$38M+217%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$126.8M+1.0%

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Warby Parker’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's investment purchases?
Warby Parker (WRBY) reported investment purchases of $0 in Q4 2025.
How has Warby Parker's investment purchases changed year-over-year?
Warby Parker's investment purchases decreased by 100.0% year-over-year, from $500K to $0.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.